Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONKO-006 adjuvant therapy with gemcitabine plus sorafenib vs gemcitabine plus placebo in R1-resected pancreatic cancer
2007-000718-35Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pancreatic cancer (PC) comparing Gemcitabine plus sorafenib with Gemcitabine plus placebo (2 arms). Primary endpoints: Disease-free survival and Overall survival. Started Oct 2007; status: completed.
02
Drugs
sorafenib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on 2007-000718-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000718-35.